To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.
After being informed of the study and potential risks, all patients who gave written informed consent were enrolled. A total of 300 eligible patients were randomly assigned in a double-blind manner and divided into experimental group and control group at a ratio of 2 : 1. The subjects were given oral test drugs ( Ganoderma lucidum spore powder or placebo ) 4g per day for 90 days from the first day after enrollment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
298
One bag at a time, 2 times a day, 2g / bag
One bag at a time, 2 times a day, 2g / bag
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Depression symptoms relieved
hamilton depression rating scale relieved from 8-20 to ≤8
Time frame: Day0,Month3
Changes of intestinal microbial diversity in patients
The increase of intestinal microbial diversity and abundance
Time frame: Day0,Month3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.